Switching from oral atypical antipsychotic monotherapy to paliperidone palmitate once-monthly in non-acute patients with schizophrenia: A prospective, open-label, interventional study
Crossref DOI link: https://doi.org/10.1007/s00213-016-4445-0
Published Online: 2016-11-05
Published Print: 2017-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Schreiner, Andreas
Caspi, Asaf
Bergmans, Paul
Cherubin, Pierre
Keim, Sofia
Lara, Elsa
Pinchuk, Irina
Schuepbach, Daniel
Suleman, Sajid
Hargarter, Ludger
License valid from 2016-11-05